Last week was a strong one for the United States Marijuana Index, which posted strong gains last week of 5.5%, and investors, along with stock experts, are hoping the positive gains are going to trickle into this week.
The United States Marijuana Index tracks 15 of the largest cannabis stocks in the United States and is showing that 2018 may be a viable year for cannabis stocks in the challenging United States market.
Here is a rundown of the numbers:
- Aurora Cannabis Inc ACBFF 2.31% gained 0.74%
- GW Pharmaceuticals PLC- ADR GWPH 1.66% gained 4.63%
- Cronos Group Inc PRMCF 4.11% gained 1.87%
- Canopy Growth Corp TWMJF 5.93% fell 5.35%
- Cannabis Sativa Inc CBDS 2.39% surged 5.93%
- THC Biomed Intl Ltd THCBF 2.18%, up 6.96%
- Aphria Inc APHQF 4.28% fell 11.14%
- Scotts Miracle-Gro Co SMG 0.31% fell 1.6%
- MedReleaf Corp MEDFF 4.94% fell 1.53%
- CannTrust Holdings Inc CNTTF 4.48% gained 1.47%
Last week also marked a big announcement from the National Association of Cannabis Businesses, the industry’s self-regulatory organization, which released the first national standards for cannabis products.
For the next month, the NACB Standard will be available on their website over at www.NACB.com for the public to review and comment on the upcoming regulations and, once in effect, all NACB members will be obliged to abide by them.
The NACB’s new guidelines will address:
- Child-resistant packaging;
- Packaging and labeling that is not appealing to minors;
- Consistent labeling, explicitly mentioning where the products come from and who if anyone processed them;
- Warning statements related to the health risks linked to the use of marijuana;
- Recommendations for people to avoid driving and operating heavy machinery while under the effects of cannabis, cannabis-infused products and cannabis-derived products;
- Ways to properly list ingredients in any product;
- How to comply with the U.S. Food & Drug Administration’s guidelines for the listing major food allergens and other related information; and
- The types of health and medical claims that cannabis products can and should make